Latest Stories
Concentrix (CNXC) Stock Is Up, What You Need To Know
Shares of customer experience solutions provider Concentrix (NASDAQ:CNXC) jumped 3.3% in the afternoon session after an analyst at Barrington Research maintained an 'Outperform' rating and a $62 price target on the stock.
Lululemon (NASDAQ:LULU) Posts Better-Than-Expected Sales In Q4 CY2025
Athletic apparel retailer Lululemon (NASDAQ:LULU) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $3.64 billion. On the other hand, next quarter’s revenue guidance of $2.42 billion was less impressive, coming in 2.1% below analysts’ estimates. Its GAAP profit of $5.01 per share was 4.9% above analysts’ consensus estimates.
DocuSign’s (NASDAQ:DOCU) Q4 CY2025: Beats On Revenue, Outlook For Next Year Is Optimistic
Electronic signature company DocuSign (NASDAQ:DOCU) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 7.8% year on year to $836.9 million. Guidance for next quarter’s revenue was better than expected at $824 million at the midpoint, 1.1% above analysts’ estimates. Its non-GAAP profit of $1.01 per share was 6.4% above analysts’ consensus estimates.
PlayStudios (NASDAQ:MYPS) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Digital casino game platform PlayStudios (NASDAQ:MYPS) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 18.3% year on year to $55.4 million. Its GAAP loss of $0.11 per share was significantly below analysts’ consensus estimates.
ZUMZ Q4 Deep Dive: Market Reacts to Margin Gains Amid Store Closures and Mixed Outlook
Clothing and footwear retailer Zumiez (NASDAQ:ZUMZ) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.4% year on year to $291.3 million. Guidance for next quarter’s revenue was optimistic at $191 million at the midpoint, 2.5% above analysts’ estimates. Its GAAP profit of $1.16 per share was 9.3% above analysts’ consensus estimates.
HCAT Q4 Deep Dive: Margin Focus and Strategic Review Amid Platform Migration Pressures
Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 6.2% year on year to $74.68 million. On the other hand, next quarter’s revenue guidance of $69 million was less impressive, coming in 7.9% below analysts’ estimates. Its non-GAAP profit of $0.08 per share was 16.1% below analysts’ consensus estimates.
LOCO Q4 Deep Dive: Menu Innovation and Expansion Propel Growth, Margin Discipline Remains Focus
Fast food chain El Pollo Loco (NASDAQ:LOCO) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.1% year on year to $123.5 million. Its non-GAAP profit of $0.25 per share was 25% above analysts’ consensus estimates.
MarineMax (HZO) Stock Is Up, What You Need To Know
Shares of boat and marine products retailer MarineMax (NYSE:HZO) jumped 3.1% in the afternoon session after the company announced the sale of a luxury 2025 Ocean Alexander 37L yacht, signaling strong demand in the high-end market.
Why Are Tandem Diabetes (TNDM) Shares Soaring Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 7.8% in the afternoon session after investment firm Piper Sandler upgraded the stock to Overweight from Neutral and increased its price target.
Why Is Lemonade (LMND) Stock Rocketing Higher Today
Shares of digital insurance provider Lemonade (NYSE:LMND) jumped 16.4% in the afternoon session after Morgan Stanley upgraded the stock to Overweight from Equalweight, citing the company's partnership with Tesla to offer auto insurance.